iBIONICS Blog

iBIONICS Selected to Exhibit at Invictus Games Accessibility Innovation Showcase in Toronto

[fa icon="calendar'] Oct 6, 2017

[fa icon="comment"] 0 Comments

iBIONICS' Cofounder and CEO, Suzanne Grant, also a Canadian Veteran, Highlights the Importance of the Invictus Games

 

iBIONICS is demonstrated how its Diamond Eye™ will restore vision at the Accessibility Innovation Showcase at the Invictus Games. The Accessibility Innovation Showcase highlighted advanced technology that can improve accessibility for people with injuries and health challenges.

 

"The Invictus Games have extra meaning to me, because I'm a veteran," says iBIONICS Cofounder and CEO Suzanne Grant who served as a Communications and Electronics Engineering Officer for 13 years from 1982 to 1995. "I've had friends and family injured while on mission, so I feel strongly about the positive impact of the Invictus Games."

 

At the Invictus Games Accessibility Innovation Showcase, Suzanne Grant presented iBIONICS' Diamond Eye and demonstrated how this game-changing technology will help blind people see again. The iBIONICS technology uses implants to replicate natural functions inside of the body. iBIONICS' solution will operate with technologies like augmented reality, artificial intelligence, advanced neurostimulation algorithms, facial recognition software, and uses virtual reality for rehabilitation.

Read More [fa icon="long-arrow-right"]

The Future of Cyborgs: Talk at Harvard University by Professor Steven Prawer

[fa icon="calendar'] Nov 23, 2016

[fa icon="comment"] 0 Comments

 

Thursday, December 1, 2016, 4-5:30 pm

Harvard University, Department of Physics, Jefferson Laboratory 250
17 Oxford Street, Cambridge, Massachusetts

 

Professor Steven Prawer, Cofounder and CTO of iBIONICS, lead inventor of the Diamond Eye and Scientific Advisor to Stentrode (as explained by President Obama on the Science Channel) provides a glimpse into the future. A future where implants, bionics, and human-machine interfaces will become the new normal.

 

Read More [fa icon="long-arrow-right"]